Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.

Wahner-Roedler DL, Nelson DF, Croghan IT, Achenbach SJ, Crowson CS, Hartmann LC, O'Fallon WM.

Mayo Clin Proc. 2003 Jun;78(6):708-15.

PMID:
12934780
2.

Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.

Lee L, Pintilie M, Hodgson DC, Goss PE, Crump M.

Ann Oncol. 2008 Jan;19(1):62-7. Epub 2007 Sep 17.

3.

Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease.

Chung CT, Bogart JA, Adams JF, Sagerman RH, Numann PJ, Tassiopoulos A, Duggan DB.

Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):405-9.

PMID:
9069314
4.

Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.

Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV.

J Clin Oncol. 2012 Aug 1;30(22):2745-52. doi: 10.1200/JCO.2011.38.8835. Epub 2012 Jun 25.

5.

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2009 Sep 10;27(26):4239-46. doi: 10.1200/JCO.2008.19.9174. Epub 2009 Aug 10.

6.

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, Kennedy J, Howell A, Wardley AM, Radford JA.

Br J Cancer. 2009 Aug 18;101(4):582-8. doi: 10.1038/sj.bjc.6605215.

7.

Breast cancer after treatment of Hodgkin's disease.

Hancock SL, Tucker MA, Hoppe RT.

J Natl Cancer Inst. 1993 Jan 6;85(1):25-31.

PMID:
8416252
8.

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH.

J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37.

9.

[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].

Cutuli B, de La Rochefordière A, Dhermain F, Borel C, Graic Y, de Lafontan B, Dilhyudy JM, Mignotte H, Tessier E, Tortochaux J, N'Guyen T, Bey P, Le Mevel-Le Pourhier A, Arriagada R.

Cancer Radiother. 1997;1(4):300-6. Review. French.

PMID:
9435820
10.

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R.

J Clin Oncol. 1994 Feb;12(2):312-25.

PMID:
8113838
11.

Management of breast cancer after Hodgkin's disease.

Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT.

J Clin Oncol. 2000 Feb;18(4):765-72.

PMID:
10673517
12.

Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.

Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J.

J Clin Oncol. 2011 Jun 20;29(18):2466-73. doi: 10.1200/JCO.2010.32.4079. Epub 2011 May 16.

13.

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS.

J Natl Cancer Inst. 2003 Jul 2;95(13):971-80.

14.

Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease.

Gervais-Fagnou DD, Girouard C, Laperriere N, Pintillie M, Goss PE.

Oncology. 1999 Oct;57(3):224-31.

PMID:
10545791
15.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
16.

Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma.

Wahner-Roedler DL, Petersen IA.

Drugs Today (Barc). 2004 Oct;40(10):865-79. Review.

PMID:
15605120
17.

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.

Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.

N Engl J Med. 2015 Dec 24;373(26):2499-511. doi: 10.1056/NEJMoa1505949.

18.

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.

Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG.

Cancer. 1997 Mar 15;79(6):1203-10.

PMID:
9070499
19.

Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation.

Dershaw DD, Yahalom J, Petrek JA.

Radiology. 1992 Aug;184(2):421-3.

PMID:
1320281
20.

Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.

Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG.

Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):69-74. doi: 10.1016/j.ijrobp.2008.03.066. Epub 2008 Jun 4.

PMID:
18538497
Items per page

Supplemental Content

Write to the Help Desk